AntineoplasticsMyelosuppression: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1847卷 / 1期

关键词：

D O I：

10.1007/s40278-021-92610-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：53 / 53

相关论文

共 50 条

[21] AntineoplasticsMyelosuppression and lung infection: case report
Reactions Weekly, 2024, 2031 (1) : 41 - 41
[22] AntineoplasticsMyelosuppression, nausea and vomiting: case report
Reactions Weekly, 2023, 1965 (1) : 63 - 63
[23] AntineoplasticsMyelosuppression and gastrointestinal reaction: case report
Reactions Weekly, 2020, 1797 (1) : 28 - 28
[24] AntineoplasticsMyelosuppression, leucopenia and thrombocytopenia: case report
Reactions Weekly, 2012, 1421 (1) : 8 - 8
[25] AntineoplasticsMyelosuppression and lack of efficacy: case report
Reactions Weekly, 2024, 2032 (1) : 52 - 52
[26] AntineoplasticsMyelosuppression and decreased cardiac function: case report
Reactions Weekly, 2021, 1847 (1) : 52 - 52
[27] Aclarubicin/AntineoplasticsMyelosuppression and drug resistance: case report
Reactions Weekly, 2019, 1740 (1) : 14 - 14
[28] AntineoplasticsMyelosuppression, thrombocytopenia and lack of efficacy: case report
Reactions Weekly, 2021, 1865 (1) : 60 - 60
[29] AntineoplasticsMyelosuppression, GI upset and fatigue: case report
Reactions Weekly, 2017, 1639 (1) : 41 - 41
[30] AntineoplasticsMyelosuppression, acrocyanosis and erythema pernio: case report
Reactions Weekly, 2023, 1965 (1) : 62 - 62

← 1 2 3 4 5 →